Clinic-based food farmacy and digital cooking program for cancer survivors
Official title: Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital
Run by M.D. Anderson Cancer Center · NCT06760754 · Data updated 2026-11-12
This program will test a clinic-linked food farmacy plus a digital culinary medicine course to try to improve diet and food security for food-insecure cancer survivors.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | March 31, 2025 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2028 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT06760754 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults treated at the MD Anderson Oncology Program at LBJ within five years of finishing acute cancer treatment who screen positive for food insecurity, receive referral to the LBJ Food Farmacy, have internet access, and can read English or Spanish.
✕Probably not a fit
Patients who are not food-insecure, not referred to the LBJ Food Farmacy, lack internet access, cannot read English or Spanish, or are more than five years off acute treatment are unlikely to benefit from this specific program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional feasibility project enrolls cancer survivors treated at the MD Anderson Oncology Program at LBJ who screen positive for food insecurity and are referred to the LBJ Food Farmacy. Participants receive a theory-driven digital culinary medicine intervention and are followed from baseline to post-intervention and at 6 months. Primary outcomes are feasibility metrics including recruitment, adherence, attrition, data completion, and satisfaction, while secondary outcomes include diet quality, food security, quality of life, and cardiometabolic biomarkers. The program requires internet access and English or Spanish literacy and collects self-report and biological measures to gauge preliminary efficacy.
Why it matters
Potential benefit: If successful, the program could improve diet quality, reduce food insecurity, enhance quality of life, and improve cardiometabolic health markers among food-insecure cancer survivors.
How similar studies have gone: Related food pharmacy and culinary medicine programs have improved diet and food security in other populations, but evidence specifically in cancer survivor populations is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer survivors treated at the MD Anderson Oncology Program at LBJ Hospital over 18 years of age. * Screen positive for food insecurity using the 2 question clinic-screener (Hunger Vital Signs) * Receive referral to the LBJ Food Farmacy. * Are within the first 5 years off of acute cancer treatment. * Self-report having internet access. * Self-report as being able to speak and read English or Spanish. * Willing to complete study assessments. Exclusion Criteria: * Unwilling or unable to complete study assessments * Anyone under 18 years of age * Self-report to not speak or read English or Spanish
Where it's running
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Margaret Raber, DRPH — M.D. Anderson Cancer Center
- Study coordinator: Maria Vazquez
- Email: mrvazquez1@mdanderson.org
- Phone: 713-792-7124
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.